JAMDA
July 18, 2023
Showing 21 - 30 of 108 results
Podcast
June 29, 2023
AMDA On-The-Go | The Past, Present & Future of Deprescribing Research (D2D Special Edition)
JAMDA
June 17, 2023
Post Hoc Analyses of a Randomized Controlled Trial for the Effect of Pharmacist Deprescribing Intervention on the Anticholinergic Burden in Frail Community-Dwelling Older Adults
Anticholinergic burden is detrimental to cognitive health. Multiple studies found that a high anticholinergic burden is associated with an increased risk for dementia, changes to the brain structure, function, and cognitive decline. We performed a post hoc analysis of a randomized controlled deprescribing ...
Podcast
June 5, 2023
Caring On-The-Go | June & July 2023
JAMDA
May 22, 2023
Factors Associated With Benzodiazepine and Antipsychotic Prescribing in Hospice: A Qualitative Study of Hospice Prescribers
Benzodiazepine and antipsychotic medications are common components of the hospice toolkit and are routinely prescribed for behavioral symptom management at end of life. These medications have significant associated risks but, despite their frequent use, little is known about how clinicians weigh prescribin...
JAMDA
May 20, 2023
Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease
The use of antipsychotics in persons with Parkinson's disease (PD) is common, although their use may aggravate the symptoms of PD. Clozapine and quetiapine are the only antipsychotics recommended in PD treatment guidelines. Information on factors associated with initiation of antipsychotics is needed....
JAMDA
April 28, 2023
Federal Nursing Home Policies on Antipsychotics had Similar Impacts by Race and Ethnicity for Residents With Dementia
Federal initiatives have been successful in reducing antipsychotic exposure in nursing home residents with dementia. We assessed if these initiatives were implemented equally across racial and ethnic minority groups.
Podcast
April 27, 2023
JAMDA On-The-Go | April 2023 | Insights into Infection Control, Oral Health, Antipsychotic Use, and Virtual Reality for Older Adults
JAMDA
April 20, 2023
Potentially Harmful Medication Prescribing by the Degree of Physician Specialization in Nursing Home Practice: An Observational Study
The use of anticholinergics, antipsychotics, benzodiazepines, and other potentially harmful medications (PHMs) is associated with particularly poor outcomes in nursing home (NH) residents with Alzheimer's disease and related dementias (ADRD). Our objective was to compare PHM prescribing by NH physicia...
Spotlight
March 31, 2023
Optimizing the Use of Gabapentin: A Special Drive to Deprescribe Podcast
Medication optimization is a hot topic in post-acute and long-term care and a focus of AMDA’s very popular Drive to Deprescribe (D2D) initiative. Now practitioners have yet another opportunity to address their deprescribing challenges with a new quarterly D2D podcast. The first program addresses Optimizing...
Tools, knowledge, and recognition to improve vaccination rates and protect residents and staff.
